87 related articles for article (PubMed ID: 4794006)
1. [Results obtained with L-DOPA and amantadine in the treatment of patients with disorders of consciousness and of the vigilant state].
Paini GP; Passoni M
Ateneo Parmense Acta Biomed; 1973 Sep; 44(5):353-9. PubMed ID: 4794006
[No Abstract] [Full Text] [Related]
2. [Amantadine in cognitive failure in patients with traumatic head injuries].
Andersson S; Berstad J; Finset A; Grimsmo J
Tidsskr Nor Laegeforen; 1992 Jun; 112(16):2070-2. PubMed ID: 1523625
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of the Parkinson syndrome with amantadine].
Hartmann-von Monakow K
Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093
[No Abstract] [Full Text] [Related]
4. [Effects of thyrotropin-releasing hormone tartrate on consciousness disturbance--preliminary report (author's transl)].
Manaka S; Fuchinoue T; Kondo T; Hori T; Sano K
No To Shinkei; 1977 Oct; 29(10):1075-81. PubMed ID: 412504
[No Abstract] [Full Text] [Related]
5. [Treatment of the parkinsonian syndrome with L-dopa and amantadine].
Pendefunda GH; Pollingher B; Stefanache F; Gavril A; Oprişan C; Merling M; Nemţeanu E; Ciuntu M; Koropitzer I
Neurol Psihiatr Neurochir; 1973; 18(6):559-68. PubMed ID: 4790488
[No Abstract] [Full Text] [Related]
6. L-dopa and amantadine hydrochloride in extra-pyramidal disorders.
Parkes JD; Knill-Jones RP; Clements PJ
Postgrad Med J; 1971 Feb; 47(544):116-9. PubMed ID: 5572526
[TBL] [Abstract][Full Text] [Related]
7. L-dopa for parkinsonism.
Reveno WS; Bauer RB; Rosenbaum H
Geriatrics; 1973 Jan; 28(1):86-8. PubMed ID: 4683093
[No Abstract] [Full Text] [Related]
8. [The addition of amantadine to prolonged treatment with L-Dopa. Considerations on 20 cases].
Giuffrè R; Gambacorta D
Minerva Med; 1971 Oct; 62(82):4009-12. PubMed ID: 5125066
[No Abstract] [Full Text] [Related]
9. [6 months of treatment with amantadine and L-Dopa. Comparison in 2 groups of patients with parkinsonism].
Buscaino GA; Campanella G; Zallone E
Minerva Med; 1971 Oct; 62(82):3974-8. PubMed ID: 5125057
[No Abstract] [Full Text] [Related]
10. The treatment of parkinsonism with L-Dopa and amantadine.
Green J
J Fla Med Assoc; 1970 Jun; 57(6):28-33. PubMed ID: 5445813
[No Abstract] [Full Text] [Related]
11. [Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa].
Ambrosetto C; Martinelli P
Minerva Med; 1971 Oct; 62(82):4017-9. PubMed ID: 5125069
[No Abstract] [Full Text] [Related]
12. [Characteristics of the disorders of consciousness in closed craniocerebral injury].
Fedenko IuZ; Zelezinskiĭ GV
Vrach Delo; 1975 Mar; (3):122-4. PubMed ID: 1121820
[No Abstract] [Full Text] [Related]
13. L-dopa and amantadine hydrochloride in Parkinson's disease.
Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
[No Abstract] [Full Text] [Related]
14. [On the therapeutic use of amantadine hydrochloride in non-parkinsonian hyperkinetic syndromes].
Borromei A
Minerva Med; 1971 Oct; 62(82):4024-6. PubMed ID: 5125071
[No Abstract] [Full Text] [Related]
15. [Iron, transferrin, copper and ceruloplasmin of the serum and cerebrospinal fluid in extrapyramidal diseases and primary myopathies. Study in basic conditions and in Parkinsonism after treatment with dopaminergic agents (L-dopa, L-dopa + RO 4-4602, amantadine)].
Campanella G; Carrieri P; Romito D; Pasqual-Marsettin E
Acta Neurol (Napoli); 1973; 28(1):1-34. PubMed ID: 4704396
[No Abstract] [Full Text] [Related]
16. Amantadine for traumatic brain injury: does it improve cognition and reduce agitation?
Leone H; Polsonetti BW
J Clin Pharm Ther; 2005 Apr; 30(2):101-4. PubMed ID: 15811161
[TBL] [Abstract][Full Text] [Related]
17. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
Sigwald J; Raymondeaud C; Piot C
Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
[No Abstract] [Full Text] [Related]
18. [Amantadine in the treatment of transitory hypokinesia in patients with parkinsonism during therapy with L-Dopa].
De Divitiis E; D'Andrea F; Signorelli CD; Cerillo A
Minerva Med; 1971 Oct; 62(82):4007-8. PubMed ID: 5125065
[No Abstract] [Full Text] [Related]
19. [Action of amantadine HCl alone and in combination with L-dopa on parkinsonism].
Danielczyk W; Korten JJ
Med Monatsschr; 1971 Oct; 25(10):472-9. PubMed ID: 5122447
[No Abstract] [Full Text] [Related]
20. [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)].
Schneider E; Fischer PA; Jacobi P
Med Klin; 1974 Mar; 69(13):541-5. PubMed ID: 4831456
[No Abstract] [Full Text] [Related]
[Next] [New Search]
